-5.16%
Today
Loading 1D prices…
Company profile
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Westlake Village, CA, United States
Employees
2
Fiscal year end
1231
CIK
2023016
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| EVMNEvommune Inc. Common Stock | $382.5M | $13M | -529.77% | -$11.22 | -0.19% | Buy |
| BIOABioAge Labs Inc. Common Stock | $389.7M | $9M | -896.11% | -$2.24 | -1.85% | Buy |
| ENTAEnanta Pharmaceuticals Inc. Common Stock | $377.5M | $50.1M | -88.82% | -$1.54 | +1.97% | Buy |
| PREPrenetics Global Limited Class A Ordinary Share | $393.8M | $92.4M | -40.82% | -$4.15 | -0.80% | Buy |
| GALTGalectin Therapeutics Inc. Common Stock | $394.3M | $0.00 | — | -$0.48 | +0.38% | Buy |